Cory Tichauer, ND - LDN and Lyme Disease I (2017 Conference) (LDN, low dose naltrexone)


Cory Tichauer, ND - LDN and Lyme Disease I  (2017 Conference) (LDN, low dose naltrexone)

Dr Cory Tichauer shares his presentation on LDN and Lyme Disease at The LDN 2017 Conference.

Dr Tichauer begins by highlighting that Chronic Lyme Disease has many overlapping symptoms from PTLS but can also involve other organ dysfunction due to active infections still causing tissue damage.

It is also stated that bacterial DNA will continue to be present in low levels in latent infections and can persist for extended periods of time following an active infection. Degraded sections found on urinary PCR testing may only support this reality.

Antigenic debris can also persist following treatment, yet Dr Tichauer proves that Low Dose Naltrexone (LDN) can be effective in preventing reinfection.

This is a summary of Dr Cory Tichauer’s presentation. Please listen to the rest of Dr Tichauer’s presentation by clicking on the video above.

Past Conferences can be found